RBR-29j956进行中（未招募）3 期
Effect of diacerein in metabolic control and acute inflammatory markers in patients with type 2 diabetes using andidiabetic agents.
适应症
试验速览
- 阶段
- 3 期
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
入选标准
- •35 years old and older; HbA1c > 7.5%; type 2 Diabete mellitus withou microalbuminuria and/or nephropaty; Using oral antihiperglicemic drugs(sulfonilureias and or metformin)
排除标准
- •Pregnant and lactating women; Chronic inflammatory diseases such as rheumatoid arthritis, osteoarthritis; Use of anti-inflammatory drugs for more than 5 days in the last 3 months; Previous diagnosis of pancreatitis; Hypersensitivity to Reina (active metabolite of diacerein) and other antraquinonic derivatives (laxative); Diabetic Nephropathy and \ or kidney failure; Liver disease (transaminases> 2.5 times the upper limit of normality); Severe gastrointestinal disease; Persistent diarrhea (> 3 stools in 24 hours); Signs of intercurrent infection; Participation in another clinical study in past 30 days; Failure to follow the research protocol; using pioglitazone;
研究者
相似试验
进行中（未招募）
3 期
Effect of diacerein on kidney function, glucose and blod fat metabolism alteration and acute inflamation indicators in type 2 diabetic patients with kidney diseaseMellitus DiabetesDiabetic nephropathyKidney Failure, ChronicE10-E14E11.2C12.777.419.780.750.500RBR-2tfwq3niversidade Federal do Rio Grande do Sul
尚未招募
4 期
To study the effect of a drug diacerein in combination with another drug aceclofenac in patients with osteoarthritis of kneesCTRI/2020/04/024744PGIMS Rohtak
已完成
2 期
Effect of Diacerein in the Metabolic Control of Patients With DM Type 2 and Secondary Failure to MetforminComplications of Diabetes MellitusDiabetes MellitusDiabetes Mellitus, Type 2NCT03208309ANS Pharma40
招募中
不适用
Study to Comapre the benefits and risk of Diacerein and Glucosamine in patients with Osteoarthritis.CTRI/2019/01/017336Dr Sruthi
Unknown
2 期
Effect of Diacerein in the Metabolic Control of Patients With DM Type 2 and Secondary Failure to MetforminDiabetes-Related ComplicationsInsulin ResistanceDiabetes Mellitus, Type 2NCT02177643University of Campinas, Brazil60